Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer

about

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer

Item

http://www.wikidata.org/entity/Q57072624

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 19 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer

@en

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer

@nl

type

Item

label

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer

@en

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer

@nl

prefLabel

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer

@en

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer

@nl

P1476

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer

@en

P2093

Rui Ma

http://www.w3.org/2001/XMLSchema#string

Xilan Yu

http://www.w3.org/2001/XMLSchema#string

Yansheng Zhai

http://www.w3.org/2001/XMLSchema#string

Yinsheng Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth

Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

Understanding the Warburg effect: the metabolic requirements of cell proliferation

Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers

Rpd3-dependent boundary formation at telomeres by removal of Sir2 substrate

S phase activation of the histone H2B promoter by OCA-S, a coactivator complex that contains GAPDH as a key component

Defining the role of mTOR in cancer

P304

394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FGENE.2018.00394

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shanshan Li

P577

2018-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30283496

http://www.w3.org/2001/XMLSchema#string

P921

molecular medicine

P932

6156463

http://www.w3.org/2001/XMLSchema#string